16 results
F-1/A
EVAX
Evaxion Biotech A/S
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
A Stable oil-in-water Emulsion, or GLA-SE. Further, the ability of immune sera to neutralize different N. gonorrhoeae strains in a bactericidal assay
F-1
EVAX
Evaxion Biotech A/S
12 Jan 24
Registration statement (foreign)
5:17pm
formulated together with the adjuvant Glucopyranosyl Lipid A Stable oil-in-water Emulsion, or GLA-SE. Further, the ability of immune sera
DRS
EVAX
Evaxion Biotech A/S
25 Jun 21
Draft registration statement
12:00am
alone (p-value <0.0001****). We also tested the 4-COMBO when formulated with another clinical stage adjuvant (oil-in-water emulsion). While
20-F
4xa frnujz3c0pm
7 Apr 21
Annual report (foreign)
4:31pm
424B4
dqtn49
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1/A
17w86e1rme95 9qi8
1 Feb 21
Registration statement (foreign) (amended)
4:56pm
F-1/A
9bw38i
25 Jan 21
Registration statement (foreign) (amended)
7:01am
F-1/A
yug tqexz
19 Jan 21
Registration statement (foreign) (amended)
5:05pm
F-1
hcu3xauop5xkyd3
8 Jan 21
Registration statement (foreign)
4:54pm
F-1
EX-10.3
rwliwk1x6o qgy
8 Jan 21
Registration statement (foreign)
4:54pm
DRS/A
gw72s sg7kdj
4 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
qcwcjm
16 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
kllux 5x9iz8yajvn
25 Nov 20
Draft registration statement (amended)
12:00am
DRS
4yptg 5ct
22 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next